All journal publications
Filters: author is de Lange [Clear All Filters]
- 2012
- 2011
- 2010
Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)),
J Pharm Sci, vol. 99, no. 5, pp. 2511-20. DOI
Online solid phase extraction with liquid chromatography-tandem mass spectrometry to analyze remoxipride in small plasma-, brain homogenate-, and brain microdialysate samples,
J Chromatogr B Analyt Technol Biomed Life Sci, vol. 878, no. 13-14, pp. 969-75. DOI
- 2009
Quantitative microdialysis using modified ultraslow microdialysis: direct rapid and reliable determination of free brain concentrations with the MetaQuant technique,
J Neurosci Methods, vol. 178, no. 2, pp. 249-54. DOI
- 2008
The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments,
J Pharmacol Toxicol Methods, vol. 57, no. 2, pp. 114-30. DOI
Mechanism-based pharmacodynamic modeling of S(-)-atenolol: estimation of in vivo affinity for the beta1-adrenoceptor with an agonist-antagonist interaction model,
J Pharmacol Exp Ther, vol. 324, no. 3, pp. 1234-42. DOI
Pharmacokinetic/pharmacodynamic modelling of the EEG effects of opioids: the role of complex biophase distribution kinetics,
Eur J Pharm Sci, vol. 34, no. 2-3, pp. 149-63. DOI
Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research,
Trends Pharmacol Sci, vol. 29, no. 4, pp. 186-91. DOI
- 2007
Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint,
Br J Pharmacol, vol. 151, no. 3, pp. 356-66. DOI
Reproducible and time-dependent modification of serum protein binding in Wistar Kyoto rats,
J Pharmacol Toxicol Methods, vol. 56, no. 1, pp. 72-8. DOI
Influence of biophase distribution and P-glycoprotein interaction on pharmacokinetic-pharmacodynamic modelling of the effects of morphine on the EEG,
Br J Pharmacol, vol. 151, no. 5, pp. 713-20. DOI
Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux,
Br J Pharmacol, vol. 151, no. 5, pp. 701-12. DOI
Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis,
Annu Rev Pharmacol Toxicol, vol. 47, pp. 357-400. DOI
Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis,
Annu Rev Pharmacol Toxicol, vol. 47, pp. 357-400. DOI
- 2005
- 2004
Transport across the blood-brain barrier: stereoselectivity and PET-tracers,
Mol Imaging Biol, vol. 6, no. 5, pp. 306-18. DOI
Potential role of ABC transporters as a detoxification system at the blood-CSF barrier,
Adv Drug Deliv Rev, vol. 56, no. 12, pp. 1793-809. DOI
- 2002
P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice,
Epilepsy Behav, vol. 3, no. 5, pp. 427-432. DOI
The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone,
J Endocrinol, vol. 175, no. 1, pp. 251-60. DOI
Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain,
Clin Pharmacokinet, vol. 41, no. 10, pp. 691-703. DOI


